又称:Hims / Hims & Hers Health, Inc.
Section 01
Section 02
| 指标 | FY2026 Q2 | FY2026 Q1 | FY2025 Q4 | FY2025 Q3 |
|---|---|---|---|---|
| 营收 | $753.21M | $608.10M | $617.82M | $598.98M |
| 毛利润 | $480.80M | $300.28M | $444.44M | $442.06M |
| 营业利润 | -$97.19M | -$16.47M | $9.19M | $11.81M |
| 净利润 | -$86.29M | -$92.11M | $20.60M | $15.77M |
| EPS | -$0.37 | -$0.4 | $0.09 | $0.07 |
| 自由现金流 | -$55.38M | $53.03M | $821,000 | $91.42M |
Section 03
本页内容由 TheMarketBrew 基于公开数据与 AI 生成,仅供研究与信息参考,不构成任何投资建议或买卖推荐。美股投资有风险,请独立判断。